Recruiting Hemophilia Studies in New Haven
About Hemophilia Clinical Trials in New Haven
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 1 hemophilia clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 130 participants. Research is being sponsored by Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in New Haven — FAQ
Are there hemophilia clinical trials in New Haven?
Yes, there are 1 hemophilia clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 1 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated March 2, 2026 from ClinicalTrials.gov